Cargando…
Acute and subchronic toxicity of the antitumor agent rhodium (II) citrate in Balb/c mice after intraperitoneal administration
This study aimed to investigate potential acute and subchronic toxicity of rhodium (II) citrate in female Balb/c mice after intraperitoneal injections. In the acute test, independent groups received five doses; the highest dose (107.5 mg/kg) was equivalent to 33 times that used in our previous repor...
Autores principales: | Carneiro, Marcella L.B., Lopes, Cláudio A.P., Miranda-Vilela, Ana L., Joanitti, Graziella A., da Silva, Izabel C.R., Mortari, Márcia R., de Souza, Aparecido R., Báo, Sônia N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598461/ https://www.ncbi.nlm.nih.gov/pubmed/28962450 http://dx.doi.org/10.1016/j.toxrep.2015.07.010 |
Ejemplares similares
-
Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer
por: Carneiro, Marcella Lemos Brettas, et al.
Publicado: (2013) -
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
por: Carneiro, Marcella LB, et al.
Publicado: (2011) -
Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay
por: Peixoto, Raphael Cândido Apolinário, et al.
Publicado: (2014) -
Modulation of fibronectin and laminin expression by Rhodium (II) citrate-coated maghemite nanoparticles in mice bearing breast tumor
por: Rocha, Márcia, et al.
Publicado: (2017) -
Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells
por: Chaves, Natalia L, et al.
Publicado: (2017)